atricure.com (ATRC): Rentabilitas operasi

AtriCure Corp (ATRC) - logo korporat

AtriCure, Inc. (ATRC) is protected by exclusive patents and stringent FDA controls, which is confirmed by the change in operating margin on the GURU.Markets chart, where 3.10 describes the current status of the metric. Revenue growth is based on the implementation of minimally invasive systems and the legal protection of rights. High demand for cardiac devices guarantees stable cash flows that are virtually independent of economic shocks.

ATRC - Rasio bathi operasi AtriCure ing rentang 04.07.2022 - 19.11.2026

Rincian analitis lan laporan data perusahaan AtriCure (ATRC)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental:ATRC, AtriCure Corp
Produk dadi atricure.com

Operating margin determines the share of profit from core operations relative to total revenue before accounting for financial expenses and taxes. For AtriCure, Inc. (ATRC), this metric reflects the efficiency of commercializing robotic cryoablation systems and automated surgical instrumentation. By analyzing the core business margin, an investor assesses the company's ability to control costs while scaling production. The indicator's trend demonstrates the model's resilience to price shocks. A stable profitability level confirms the high quality of the issuer's assets.

Analisis pesaing AtriCure, Inc.

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Rentabilitas dodolan operasi|ZimVie Inc - Margin operasi|Rentabilitas dodolan operasi AngioDynamics|CERS (Cerus Corp) - Margin dodolan operasi|Alpha Teknova, Inc. - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi